{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:04:08Z","timestamp":1792105448571,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.urology.2011.04.076","type":"journal-article","created":{"date-parts":[[2011,10,3]],"date-time":"2011-10-03T02:15:09Z","timestamp":1317608109000},"page":"1373-1378","source":"Crossref","is-referenced-by-count":24,"title":["Serum C-reactive Protein Levels are Associated With Residual Urgency Symptoms in Patients With Benign Prostatic Hyperplasia After Medical Treatment"],"prefix":"10.1016","volume":"78","author":[{"given":"Chun-Hou","family":"Liao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Dong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2011.04.076_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-Committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2011.04.076_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib4","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0090-4295(01)01413-3","article-title":"Symptoms, prostate volume, and urodynamic findings in elderly male volunteers without and with LUTS and in patients with LUTS suggestive of benign prostatic hyperplasia","volume":"58","author":"Eckhardt","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.076_bib5","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib6","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/00005392-199907000-00035","article-title":"Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly men","volume":"162","author":"Ameda","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib7","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0022-5347(05)65862-4","article-title":"Videourodynamic studies in men with lower urinary tract symptoms: a comparison of community based versus referral urological practices","volume":"166","author":"Fusco","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib8","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0022-5347(05)65982-4","article-title":"Detrusor instability in men: correlation of lower urinary tract symptoms with urodynamic findings","volume":"166","author":"Hyman","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1464-410X.2005.05294.x","article-title":"The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects","volume":"95","author":"Chapple","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2011.04.076_bib10","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0022-5347(05)65985-X","article-title":"Prevalence and bothersomeness of lower urinary tract symptoms in benign prostatic hyperplasia and their impact on well-being","volume":"166","author":"Eckhardt","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib11","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2011.04.076_bib12","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1023\/A:1014457808748","article-title":"Symptoms and urodynamics after unsuccessful transurethral prostatectomy","volume":"32","author":"Ignjatovic","year":"2001","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.urology.2011.04.076_bib13","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000048427","article-title":"Analysis of the pathophysiology of lower urinary tract symptoms in patients after prostatectomy","volume":"68","author":"Kuo","year":"2002","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2011.04.076_bib14","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/S0022-5347(05)00313-7","article-title":"Overactive bladder: a better understanding of pathophysiology, diagnosis and management","volume":"175","author":"Wein","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1464-410X.2006.06574.x","article-title":"The role of anticholinergics in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis","volume":"99","author":"Blake-James","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2011.04.076_bib16","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5347(17)56980-3","article-title":"Patterns of inflammation in prostatic hyperplasia: a histologic and bacteriologic study","volume":"121","author":"Kohnen","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11918-008-0011-5","article-title":"Inflammatory Mechanisms Associated with prostatic Inflammation and Lower Urinary Tract Symptoms","volume":"6","author":"St. Sauver","year":"2008","journal-title":"Curr Prostate Reprod"},{"key":"10.1016\/j.urology.2011.04.076_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0302-2838(02)00548-1","article-title":"Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis","volume":"43","author":"Di Silverio","year":"2003","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib19","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/pros.20110","article-title":"Serum C-reactive protein concentration and lower urinary tract symptoms in older men in the third National Health and Nutrition Examination Survey (NHANES III)","volume":"62","author":"Rohrmann","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.urology.2011.04.076_bib21","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/aje\/kwp085","article-title":"Associations between C-reactive protein and benign prostatic hyperplasia\/lower urinary tract symptom outcomes in a population-based cohort","volume":"169","author":"St Sauver","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.urology.2011.04.076_bib22","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2008.12.012","article-title":"Association of C-reactive protein and lower urinary tract symptoms in men and women: results from Boston Area Community Health survey","volume":"73","author":"Kupelian","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.076_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/01.ju.0000165461.38088.7b","article-title":"A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials","volume":"174","author":"Nixon","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib24","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/nau.20938","article-title":"Elevation of serum c-reactive protein in patients with overactive bladder and IC\/BPS implies chronic inflammation in the urinary bladder","volume":"30","author":"Chung","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2011.04.076_bib25","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11934-996-0008-y","article-title":"Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"7","author":"Kasturi","year":"2006","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.urology.2011.04.076_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/07853890500401234","article-title":"The metabolic syndrome and cardiovascular disease","volume":"38","author":"Bonora","year":"2006","journal-title":"Ann Med"},{"key":"10.1016\/j.urology.2011.04.076_bib27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/nau.20500","article-title":"LUTS treatment: future treatment options","volume":"26","author":"Andersson","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.urology.2011.04.076_bib28","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.eururo.2004.08.024","article-title":"Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)","volume":"47","author":"Di Silverio","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2011.04.076_bib29","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.urology.2009.01.088","article-title":"Combination therapy with doxazosin and tenoxicam for the management of lower urinary tract symptoms","volume":"74","author":"Ozdemir","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.076_bib30","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.urology.2008.04.069","article-title":"Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study","volume":"72","author":"Falahatkar","year":"2008","journal-title":"Urology"},{"key":"10.1016\/j.urology.2011.04.076_bib31","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-5347(05)00984-5","article-title":"Clinical usefulness of serum prostate specific antigen for the detection of prostate cancer is preserved in men receiving the dual 5alpha-reductase inhibitor dutasteride","volume":"175","author":"Andriole","year":"2006","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511020863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429511020863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,16]],"date-time":"2019-06-16T19:04:08Z","timestamp":1560711848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429511020863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0090429511020863"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2011.04.076","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}